Multidisciplinary Approach in Atrial Fibrillation: As Good As Gold

Overview

Journal J Clin Med

Specialty General Medicine

Date 2024 Aug 29

PMID 39200763

Authors

Fabiana Luca

Maurizio Giuseppe Abrignani

Fabrizio Oliva

Maria Laura Canale

Iris Parrini

Adriano Murrone

Carmelo Massimiliano Rao

Martina Nesti

Stefano Cornara

Irene Di Matteo

Michela Barisone

Simona Giubilato

Roberto Ceravolo

Carlo Pignalberi

Giovanna Geraci

Carmine Riccio

Sandro Gelsomino

Furio Colivicchi

Massimo Grimaldi

Michele Massimo Gulizia

Affiliations

Soon will be listed here.

Abstract

Atrial fibrillation (AF) represents the most common sustained arrhythmia necessitating dual focus: acute complication management and sustained longitudinal oversight to modulate disease progression and ensure comprehensive patient care over time. AF is a multifaceted disorder; due to such a great number of potential exacerbating conditions, a multidisciplinary team (MDT) should manage AF patients by cooperating with a cardiologist. Effective management of AF patients necessitates the implementation of a well-coordinated and tailored care pathway aimed at delivering optimized treatment through collaboration among various healthcare professionals. Management of AF should be carefully evaluated and mutually agreed upon in consultation with healthcare providers. It is crucial to recognize that treatment may evolve due to the emergence of new risk factors, symptoms, disease progression, and advancements in treatment modalities. In the context of multidisciplinary AF teams, a coordinated approach involves assembling a diverse team tailored to meet individual patients' unique needs based on local services' availability.

Citing Articles

Advances in Atrial Fibrillation Management: A Guide for General Internists.

Pham H, Ibrahim R, Truong H, Sainbayar E, Tran V, Abdelnabi M J Clin Med. 2025; 13(24.

PMID: 39768769 PMC: 11678337. DOI: 10.3390/jcm13247846.

References

Yue X, Zhou L, Li Y, Zhao C . Multidisciplinary management strategies for atrial fibrillation. Curr Probl Cardiol. 2024; 49(6):102514. DOI: 10.1016/j.cpcardiol.2024.102514. View

Martinez B, Sood N, Bunz T, Coleman C . Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation. J Am Heart Assoc. 2018; 7(8). PMC: 6015429. DOI: 10.1161/JAHA.118.008643. View

Hayashi H, Miyamoto A, Kawaguchi T, Naiki N, Xue J, Matsumoto T . P-pulmonale and the development of atrial fibrillation. Circ J. 2013; 78(2):329-37. DOI: 10.1253/circj.cj-13-0654. View

Chugh S, Blackshear J, Shen W, Hammill S, Gersh B . Epidemiology and natural history of atrial fibrillation: clinical implications. J Am Coll Cardiol. 2001; 37(2):371-8. DOI: 10.1016/s0735-1097(00)01107-4. View

Tukek T, Yildiz P, Akkaya V, Karan M, Atilgan D, Yilmaz V . Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol. 2002; 7(3):222-7. PMC: 7027775. DOI: 10.1111/j.1542-474x.2002.tb00167.x. View

Patti G, Lucerna M, Pecen L, Siller-Matula J, Cavallari I, Kirchhof P . Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (vention o Thromboembolic Events-uropean egistry in trial ibrillation). J Am Heart Assoc. 2017; 6(7). PMC: 5586290. DOI: 10.1161/JAHA.117.005657. View

Okumura K, Akao M, Yoshida T, Kawata M, Okazaki O, Akashi S . Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation. N Engl J Med. 2020; 383(18):1735-1745. DOI: 10.1056/NEJMoa2012883. View

Clegg A, Young J, Iliffe S, Rikkert M, Rockwood K . Frailty in elderly people. Lancet. 2013; 381(9868):752-62. PMC: 4098658. DOI: 10.1016/S0140-6736(12)62167-9. View

Adejumo A, Adejumo K, Akanbi O, Adegbala O, Alayo Q, Fijabi D . Predictors, burden and impact of cardiac arrhythmias among patients hospitalized with end-stage liver disease. Heart Lung. 2019; 49(1):73-79. DOI: 10.1016/j.hrtlng.2019.07.002. View

10.

Khasnis A, Thakur R . Atrial fibrillation: a historical perspective. Cardiol Clin. 2008; 27(1):1-12, vii. DOI: 10.1016/j.ccl.2008.09.013. View

11.

Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S . Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6:213-20. PMC: 4064952. DOI: 10.2147/CLEP.S47385. View

12.

Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo C . Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J. 2010; 31(11):1344-56. PMC: 2878965. DOI: 10.1093/eurheartj/ehq041. View

13.

Yang P, Sung J, Jang E, Yu H, Kim T, Lip G . Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: A nationwide cohort study. J Arrhythm. 2020; 36(4):668-677. PMC: 7411200. DOI: 10.1002/joa3.12364. View

14.

Margulescu A, Mont L . Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management. Expert Rev Cardiovasc Ther. 2017; 15(8):601-618. DOI: 10.1080/14779072.2017.1355237. View

15.

Anter E, Di Biase L, Contreras-Valdes F, Gianni C, Mohanty S, Tschabrunn C . Atrial Substrate and Triggers of Paroxysmal Atrial Fibrillation in Patients With Obstructive Sleep Apnea. Circ Arrhythm Electrophysiol. 2017; 10(11). PMC: 5726812. DOI: 10.1161/CIRCEP.117.005407. View

16.

Klersy C, De Silvestri A, Gabutti G, Raisaro A, Curti M, Regoli F . Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail. 2011; 13(4):450-9. DOI: 10.1093/eurjhf/hfq232. View

17.

Bhat A, Khanna S, Chen H, Gupta A, Gan G, Denniss A . Integrated Care in Atrial Fibrillation: A Road Map to the Future. Circ Cardiovasc Qual Outcomes. 2021; 14(3):e007411. PMC: 7982130. DOI: 10.1161/CIRCOUTCOMES.120.007411. View

18.

Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E . 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023; 83(1):109-279. PMC: 11104284. DOI: 10.1016/j.jacc.2023.08.017. View

19.

Proietti M, Cesari M . Describing the relationship between atrial fibrillation and frailty: Clinical implications and open research questions. Exp Gerontol. 2021; 152:111455. DOI: 10.1016/j.exger.2021.111455. View

20.

Luca F, Gulizia M, Abrignani M, Benedetto F, Bisceglia I, Bisignani G . [ANMCO Position paper: Choosing Wisely - ANMCO proposals for 2023]. G Ital Cardiol (Rome). 2023; 24(9):754-765. DOI: 10.1714/4084.40686. View